Page 51 - ISBD 2018
P. 51
POSTER ABSTRACT NUMBER DATE NUMBER
057 9-10 MARCH, 2018 ISBD8-0059
INTEGRATION OF PHARMACOLOGICAL, SOMATIC AND PSYCHOLOGICAL TREATMENT
A META-ANALYSIS OF EFFICACY AND SAFETY OF TREATMENTS IN BIPOLAR DEPRESSION IN RANDOMIZED CONTROLLED TRIALS
Dr Hagi, Katsuhiko (Japan)
058 9-10 MARCH, 2018 ISBD8-0259
INTEGRATION OF PHARMACOLOGICAL, SOMATIC AND PSYCHOLOGICAL TREATMENT
RESIDUAL DEPRESSIVE SYMPTOMS IN BIPOLAR I DISORDERS PATIENTS: IMPACT OF PHYSICAL ACTIVITY
Ms Miranda-Pettersen, Karine (Brazil)
059 9-10 MARCH, 2018 ISBD8-0221
PHYSIOLOGICAL, MOLECULAR, CELLULAR MARKERS AND MODELS
THE IMPACT OF BODY MASS INDEX ON GENE EXPRESSION OF REELIN PATHWAY MEDIATORS IN INDIVIDUALS WITH SCHIZOPHRENIA AND MOOD DISORDERS: A POSTMORTEM STUDY
Prof Dr Brietzke, Elisa (Brazil)
060 9-10 MARCH, 2018 ISBD8-0222
PHYSIOLOGICAL, MOLECULAR, CELLULAR MARKERS AND MODELS
THE EFFECT OF BODY MASS INDEX ON GLUCAGON-LIKE PEPTIDE RECEPTOR GENE EXPRESSION IN THE POST MORTEM BRAIN FROM INDIVIDUALS WITH MOOD AND PSYCHOTIC DISORDERS
Prof Dr Brietzke, Elisa (Brazil)
061 9-10 MARCH, 2018 ISBD8-0140
PHYSIOLOGICAL, MOLECULAR, CELLULAR MARKERS AND MODELS
CYTOMEGALOVIRUS / TOXOPLASMA ANTIBODY TITERS IN BIPOLAR DISORDER
Dr Frye, Mark (USA)
062 9-10 MARCH, 2018 ISBD8-0231
PHYSIOLOGICAL, MOLECULAR, CELLULAR MARKERS AND MODELS
TRANSACTIVE RESPONSE DNA-BINDING PROTEIN 43 AS A NEUROMARKER OF BIPOLAR DISORDER
Prof Nascimento, Camila (Brazil)
51
